AM-6545

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAM-6545
Drug Alias NameAM-6545
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMetabolic DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMakScientific Llc
China Registration ClassN/A

Develop Information

Active CompaniesMakScientific Llc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A